175 related articles for article (PubMed ID: 2162789)
41. Genotyping steroid 21-hydroxylase deficiency: hormonal reference data.
New MI; Lorenzen F; Lerner AJ; Kohn B; Oberfield SE; Pollack MS; Dupont B; Stoner E; Levy DJ; Pang S; Levine LS
J Clin Endocrinol Metab; 1983 Aug; 57(2):320-6. PubMed ID: 6306039
[TBL] [Abstract][Full Text] [Related]
42. Late-onset congenital adrenal hyperplasia in women with hirsutism.
Arnaout MA
Eur J Clin Invest; 1992 Oct; 22(10):651-8. PubMed ID: 1333959
[TBL] [Abstract][Full Text] [Related]
43. Clinical and biological phenotypes in late-onset 21-hydroxylase deficiency.
Dewailly D; Vantyghem-Haudiquet MC; Sainsard C; Buvat J; Cappoen JP; Ardaens K; Racadot A; Lefebvre J; Fossati P
J Clin Endocrinol Metab; 1986 Aug; 63(2):418-23. PubMed ID: 3013919
[TBL] [Abstract][Full Text] [Related]
44. Late-onset adrenal hyperplasia in hirsutism.
Kuttenn F; Couillin P; Girard F; Billaud L; Vincens M; Boucekkine C; Thalabard JC; Maudelonde T; Spritzer P; Mowszowicz I
N Engl J Med; 1985 Jul; 313(4):224-31. PubMed ID: 2989686
[TBL] [Abstract][Full Text] [Related]
45. Is heterozygosity for the steroid 21-hydroxylase deficiency responsible for hirsutism, premature pubarche, early puberty, and precocious puberty in children?
Knorr D; Bidlingmaier F; Höller W; Kuhnle U; Meiler B; Nachmann A
Acta Endocrinol Suppl (Copenh); 1986; 279():284-9. PubMed ID: 3022523
[TBL] [Abstract][Full Text] [Related]
46. The hypothalamic-pituitary-adrenal axis in critical illness: response to dexamethasone and corticotropin-releasing hormone.
Reincke M; Allolio B; Würth G; Winkelmann W
J Clin Endocrinol Metab; 1993 Jul; 77(1):151-6. PubMed ID: 8392081
[TBL] [Abstract][Full Text] [Related]
47. Angiotensin and adrenal steroidogenesis: study of 21-hydroxylase-deficient congenital adrenal hyperplasia.
Schaison G; Couzinet B; Gourmelen M; Elkik F; Bougneres P
J Clin Endocrinol Metab; 1980 Dec; 51(6):1390-4. PubMed ID: 7002950
[TBL] [Abstract][Full Text] [Related]
48. Detection of late-onset 21-hydroxylase deficiency congenital adrenal hyperplasia in adolescents.
Emans SJ; Grace E; Fleischnick E; Mansfield MJ; Crigler JF
Pediatrics; 1983 Nov; 72(5):690-5. PubMed ID: 6314235
[TBL] [Abstract][Full Text] [Related]
49. Pituitary-ovarian responses to leuprolide acetate testing in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Ghizzoni L; Virdis R; Vottero A; Cappa M; Street ME; Zampolli M; Ibañez L; Bernasconi S
J Clin Endocrinol Metab; 1996 Feb; 81(2):601-6. PubMed ID: 8636275
[TBL] [Abstract][Full Text] [Related]
50. The role of adrenocorticotropin testing in evaluating girls with premature adrenarche and hirsutism/oligomenorrhea.
Hawkins LA; Chasalow FI; Blethen SL
J Clin Endocrinol Metab; 1992 Feb; 74(2):248-53. PubMed ID: 1309832
[TBL] [Abstract][Full Text] [Related]
51. Prevalence of late-onset adrenal hyperplasia in postmenarchal hirsutism.
Motta P; Catania A; Airaghi L; Mangone I; Cantalamessa L; Zanussi C
J Endocrinol Invest; 1988 Oct; 11(9):675-8. PubMed ID: 2851623
[TBL] [Abstract][Full Text] [Related]
52. Fertility in women with late-onset adrenal hyperplasia due to 21-hydroxylase deficiency.
Feldman S; Billaud L; Thalabard JC; Raux-Demay MC; Mowszowicz I; Kuttenn F; Mauvais-Jarvis P
J Clin Endocrinol Metab; 1992 Mar; 74(3):635-9. PubMed ID: 1310999
[TBL] [Abstract][Full Text] [Related]
53. Comparison of basal and adrenocorticotropin-stimulated plasma 21-deoxycortisol and 17-hydroxyprogesterone values as biological markers of late-onset adrenal hyperplasia.
Fiet J; Gueux B; Gourmelen M; Kuttenn F; Vexiau P; Couillin P; Pham-Huu-Trung MT; Villette JM; Raux-Demay MC; Galons H
J Clin Endocrinol Metab; 1988 Apr; 66(4):659-67. PubMed ID: 2831244
[TBL] [Abstract][Full Text] [Related]
54. Augmented 17 alpha-hydroxyprogesterone response to ACTH stimulation as evidence of decreased 21-hydroxylase activity in patients with incidentally discovered adrenal tumours ('incidentalomas').
Seppel T; Schlaghecke R
Clin Endocrinol (Oxf); 1994 Oct; 41(4):445-51. PubMed ID: 7955456
[TBL] [Abstract][Full Text] [Related]
55. Pituitary-adrenal axis activity in treated congenital adrenal hyperplasia: static and dynamic studies.
Pham-Huu-Trung MT; Gourmelen M; Raux-Eurin MC; Girard F
J Clin Endocrinol Metab; 1978 Aug; 47(2):422-7. PubMed ID: 233672
[TBL] [Abstract][Full Text] [Related]
56. Isolated precocious pubarche: an approach.
Balducci R; Boscherini B; Mangiantini A; Morellini M; Toscano V
J Clin Endocrinol Metab; 1994 Aug; 79(2):582-9. PubMed ID: 8045980
[TBL] [Abstract][Full Text] [Related]
57. Pituitary and adrenal responses to pulsatile ovine corticotropin-releasing factor administered to fetal sheep.
Brooks AN; Challis JR; Norman LJ
Endocrinology; 1987 Jun; 120(6):2383-8. PubMed ID: 3032589
[TBL] [Abstract][Full Text] [Related]
58. Attenuated forms of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Lee PA; Rosenwaks Z; Urban MD; Migeon CJ; Bias WD
J Clin Endocrinol Metab; 1982 Nov; 55(5):866-71. PubMed ID: 6288754
[TBL] [Abstract][Full Text] [Related]
59. Corticotropin-releasing factor receptors and pituitary adrenal responses during immobilization stress.
Hauger RL; Millan MA; Lorang M; Harwood JP; Aguilera G
Endocrinology; 1988 Jul; 123(1):396-405. PubMed ID: 2838259
[TBL] [Abstract][Full Text] [Related]
60. Pioglitazone reduces the adrenal androgen response to corticotropin-releasing factor without changes in ACTH release in hyperinsulinemic women with polycystic ovary syndrome.
Romualdi D; Giuliani M; Draisci G; Costantini B; Cristello F; Lanzone A; Guido M
Fertil Steril; 2007 Jul; 88(1):131-8. PubMed ID: 17336978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
